Daxor Corporation to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Core Insights - Daxor Corporation will present at the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10, 2025, in New York City [1] - The presentation will be available on-demand starting September 5, 2025, at 7:00 a.m. ET [1] Company Overview - Daxor Corporation is addressing a significant issue in healthcare, specifically the inability to accurately measure blood volume, which can lead to suboptimal patient care and increased hospital stays [3] - The company has developed a patented, FDA-cleared Blood Volume Analysis (BVA) diagnostic system that provides real-time, precise data, enabling clinicians to make better treatment decisions [3] - Daxor has 50 years of experience in the field and operates a state-of-the-art 20,000-square-foot manufacturing facility in the U.S., positioning it for market expansion [3] Investor Engagement - Investors interested in the presentation can register for the conference through a provided link [2] - CEO Michael Feldschuh will be available for one-on-one meetings with registered investors at the conference [2] - For further inquiries, investors can contact Bret Shapiro at CORE IR via phone or email [2][6]